BA
ALBO

BlackRock Advisors’s Albireo Pharma Inc ALBO Stock Holding History

BlackRock Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-193
Closed -$13K – 3733
2014
Q2 		$13K Hold
193
– – ﹤0.01% 3534
2014
Q1 		$16K Buy
193
+84
+77% +$7.64K ﹤0.01% 3465
2013
Q4 		$7K Hold
109
– – ﹤0.01% 3551
2013
Q3 		$10K Buy
109
+30
+38% +$3.91K ﹤0.01% 3466
2013
Q2 		$10K Buy
+79
New +$8.22K ﹤0.01% 3421

Other funds holding ALBO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $126M AUM 15.32% 1-Year Est. Return

BlackRock Advisors's ALBO Position: Q3 2014 in Review

BlackRock Advisors sold out of Albireo Pharma Inc (ALBO) in Q3 2014, closing a stake of 193 shares — an estimated $13K sold.

BlackRock Advisors first reported a position in ALBO in Q2 2013 and held it in 5 quarters. The position peaked at $16K in Q1 2014. 41 funds tracked by Wall St. Rank hold ALBO as of Q3 2014.

  • BlackRock Advisors reported no remaining Albireo Pharma Inc position as of Q3 2014 after selling out during the quarter.
  • BlackRock Advisors sold 193 Albireo Pharma Inc shares in Q3 2014, an estimated $13K.
  • BlackRock Advisors first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 5 quarters.
  • BlackRock Advisors's Albireo Pharma Inc position peaked at $16K in Q1 2014.
  • 41 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2014.

Based on BlackRock Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.